Tracleer (bosentan), the first ORAL drug approved for pulmonary arterial hypertension

Actelion Pharmaceuticals is now promoting Tracleer (bosentan), the first ORAL drug approved for pulmonary arterial hypertension.

Pulmonary arterial hypertension is a rare but deadly disorder. It often leads to heart failure and death within 3 years.

Usual treatments include anticoagulants...calcium channel blockers...continuous IV infusions of Flolan (epoprostenol)...or surgery.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote